In a report published late last month in the medical journal The BMJ , a group of American and Chinese researchers raise potential safety concerns about GLP-1 drugs, indicating that higher doses of the drugs were linked to increased risks of experiencing symptoms consistent with stomach paralysis, including persistent nausea, vomiting and irregular bowel movements
Sundar IK, Chung S, Hwang JW, Arunachalam G, Cook S, Yao H, Mazur W, Kinnula VL, Fisher AB, Rahman I: Peroxiredoxin 6 differentially regulates acute and chronic cigarette smokemediated lung inflammatory response and injury
Skin Dryness : Users may experience dry, itchy skin, which can escalate to eczema or cracked skin, increasing the risk of infections
Despite promising research, it is important to exercise caution when considering the potential benefits of GLP-1 agonists beyond diabetes and obesity